This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)
60 results

Products

Health GSK is the trusted resource for Cyprus healthcare professionals containing products and disease information, patient and clinical information, webcasts and events

Safety

Relvar Ellipta summary of safety – including information about active components

Salford Lung Study in Asthma - EU

Relvar (fluticasone furoate/vilanterol, FF/VI) Ellipta▼ summary of key findings in the Salford Lung Study (SLS) for asthma patients

Efficacy

Relvar Ellipta summary of efficacy in asthma and COPD – including information about active components

Dosage and Administration

Relvar Ellipta dosing and administration information – including information on the Ellipta inhaler and dose adjustments

Frequently Asked Questions

Frequently asked questions on Relvar Ellipta for asthma and COPD

Relvar (Asthma) clinical evidence

Clinical evidence for healthcare professionals supporting the prescribing of Relvar Ellipta (fluticasone furoate/vilanterol)

Relvar (COPD) core clinical evidence

Information for healthcare professionals about the clinical evidence supporting the prescribing of Relvar Ellipta (fluticasone furoate/vilanterol) for COPD

Product Summary

Relvar Ellipta product information – including outline of key benefits in asthma and COPD and an introduction to Relvar mode of action

Uncovering patient symptoms

How well-controlled is asthma in your patients? Emerging evidence suggests that people may not always report symptoms to their physician, perhaps because they have learned to live with them.

Relvar Ellipta

fluticasone furoate / vilanterol<br/> Respiratory

Incruse▼Ellipta

umeclidinium<br> Respiratory

Anoro▼Ellipta

umeclidinium / vilanterol inhalation powder<br/> Respiratory

IMD Transmission

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero

Bexsero

Meningococcal group B vaccine (rDNA, component, adsorbed) <br> Vaccines

Augmentin

amoxicillin and clavulanate<br> Anti-infectives

How Nucala Works

Description of nucala, how nucala works, eosinophil, mechanism of action

appropriate-patients

Appropriate patients

show more